Table 6.

Linear regression between SF-36 PCS and UCLA SCTC GITI score adjusted for age, disease duration, sex, and ethnicity (n = 113).

ßStandard Error95% CI for ßp
Dependent variable = SF-36 MCS
  UCLA SCTC GITI score−6.942.27−11.44; −2.440.0029
  Age−0.040.09−0.21; −0.140.7006
  Disease duration0.080.10−0.12; 0.280.4397
  White ethnicity2.342.97−3.54; 8.230.4317
  Women vs men R2 adj = 0.046212.043.43−4.75; 8.820.5536
Dependent variable = SF-36 PCS
  UCLA SCTC GITI score−7.312.43−12.12; −2.49< 0.001
  Age−0.130.10−0.32; 0.060.0033
  Disease duration−0.090.11−0.31; 0.130.1922
  White ethnicity2.363.18−3.93; 8.650.4599
  Women vs men R2 adj = 0.046211.963.67−5.29; 9.220.5932
  • SF-36: Medical Outcomes Study Short-Form 36 questionnaire; MCS: mental component summary; PCS: physical component summary; UCLA SCTC GITI: University of California at Los Angeles Scleroderma Clinical Trial Consortium GI Tract Instrument.